{"id":"https://openalex.org/W2118123147","doi":"https://doi.org/10.1161/jaha.112.002279","title":"Effect of Bromocriptine\u2010QR (a Quick\u2010Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects","display_name":"Effect of Bromocriptine\u2010QR (a Quick\u2010Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects","alternate_titles":[],"publication_year":2012,"publication_date":"2012-09-26","ids":{"openalex":"https://openalex.org/W2118123147","doi":"https://doi.org/10.1161/jaha.112.002279","mag":"2118123147","pmid":"https://pubmed.ncbi.nlm.nih.gov/23316290","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3541616"},"language":"en","primary_location":{"id":"doi:10.1161/jaha.112.002279","doi":"https://doi.org/10.1161/jaha.112.002279","is_oa":true,"landing_page_url":"https://doi.org/10.1161/jaha.112.002279","pdf_url":null,"source":{"id":"https://openalex.org/S2489920150","display_name":"Journal of the American Heart Association","issn_l":"2047-9980","issn":["2047-9980"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Heart Association","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2118123147"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1161/jaha.112.002279","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012460833","display_name":"J. Michael Gaziano","orcid":"https://orcid.org/0000-0002-5384-9767","observed_orcids":["https://orcid.org/0000-0002-5384-9767"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Michael Gaziano","raw_affiliation_strings":["Massachusetts Veterans Epidemiology, Research and Information Center, Veterans Affairs Healthcare System Boston, Divisions of Aging, Cardiology, Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts Veterans Epidemiology, Research and Information Center, Veterans Affairs Healthcare System Boston, Divisions of Aging, Cardiology, Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I2799886695","https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084493896","display_name":"Anthony H. Cincotta","orcid":"https://orcid.org/0000-0002-8329-3341","observed_orcids":["https://orcid.org/0000-0002-8329-3341"]},"institutions":[{"id":"https://openalex.org/I4210158314","display_name":"Veroscience (United States)","ror":"https://ror.org/0596vwe73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158314"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anthony H. Cincotta","raw_affiliation_strings":["VeroScience LLC, 1334 Main Road, Tiverton, RI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VeroScience LLC, 1334 Main Road, Tiverton, RI","institution_ids":["https://openalex.org/I4210158314"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088412188","display_name":"Aaron I. Vinik","orcid":"https://orcid.org/0000-0002-5279-0628","observed_orcids":["https://orcid.org/0000-0002-5279-0628"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aaron Vinik","raw_affiliation_strings":["The Strelitz Diabetes Center and Neuroendocrine Unit, Norfolk, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Strelitz Diabetes Center and Neuroendocrine Unit, Norfolk, VA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070289715","display_name":"Lawrence Blonde","orcid":"https://orcid.org/0000-0003-0492-6698","observed_orcids":["https://orcid.org/0000-0003-0492-6698"]},"institutions":[{"id":"https://openalex.org/I2799767083","display_name":"Ochsner Medical Center","ror":"https://ror.org/0290qyp66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336053918","https://openalex.org/I2799767083"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lawrence Blonde","raw_affiliation_strings":["Department of Endocrinology, Ochsner Medical Center, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology, Ochsner Medical Center, New Orleans, LA","institution_ids":["https://openalex.org/I2799767083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113758902","display_name":"Nancy J.V. Bohannon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nancy Bohannon","raw_affiliation_strings":["St. Luke's Hospital, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. Luke's Hospital, San Francisco, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111960607","display_name":"Richard E. Scranton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158314","display_name":"Veroscience (United States)","ror":"https://ror.org/0596vwe73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158314"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Scranton","raw_affiliation_strings":["VeroScience LLC, 1334 Main Road, Tiverton, RI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VeroScience LLC, 1334 Main Road, Tiverton, RI","institution_ids":["https://openalex.org/I4210158314"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5084493896"],"corresponding_institution_ids":["https://openalex.org/I4210158314"],"apc_list":{"value":3810,"currency":"USD","value_usd":3810},"apc_paid":{"value":3810,"currency":"USD","value_usd":3810},"fwci":4.336,"has_fulltext":true,"cited_by_count":98,"citation_normalized_percentile":{"value":0.94632461,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"1","issue":"5","first_page":"e002279","last_page":"e002279"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bromocriptine-mesylate","display_name":"bromocriptine mesylate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9789999723434448},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.8009999990463257},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9769999980926514},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.9929999709129333},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.6340000033378601},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-agonist","display_name":"dopamine D2 receptor agonist","score":0.8199999928474426},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.6499999761581421},{"id":"https://openalex.org/keywords/cardiovascular-risk-stratification","display_name":"cardiovascular risk stratification","score":0.5400000214576721},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.6610000133514404},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.492000013589859},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.3630000054836273},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9533109664916992},{"id":"https://openalex.org/C2776856834","wikidata":"https://www.wikidata.org/wiki/Q413581","display_name":"Bromocriptine","level":4,"score":0.847724199295044},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6673200130462646},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6140934228897095},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5072488188743591},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4212193191051483},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3612974286079407},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3277198076248169},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.09395638108253479},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.06668281555175781}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001971","descriptor_name":"Bromocriptine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D057194","descriptor_name":"Intention to Treat Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1161/jaha.112.002279","doi":"https://doi.org/10.1161/jaha.112.002279","is_oa":true,"landing_page_url":"https://doi.org/10.1161/jaha.112.002279","pdf_url":null,"source":{"id":"https://openalex.org/S2489920150","display_name":"Journal of the American Heart Association","issn_l":"2047-9980","issn":["2047-9980"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Heart Association","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3541616","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3541616/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3541616/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Am Heart Assoc","raw_type":"Text"},{"id":"pmid:23316290","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23316290","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Heart Association","raw_type":"Journal Article"},{"id":"pmh:oai:dash.harvard.edu:1/10655802","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:10655802","pdf_url":null,"source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1161/jaha.112.002279","doi":"https://doi.org/10.1161/jaha.112.002279","is_oa":true,"landing_page_url":"https://doi.org/10.1161/jaha.112.002279","pdf_url":null,"source":{"id":"https://openalex.org/S2489920150","display_name":"Journal of the American Heart Association","issn_l":"2047-9980","issn":["2047-9980"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Heart Association","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2118123147.pdf","grobid_xml":"https://content.openalex.org/works/W2118123147.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W172609984","https://openalex.org/W1502029423","https://openalex.org/W1584861882","https://openalex.org/W1971122483","https://openalex.org/W1974125119","https://openalex.org/W1983094335","https://openalex.org/W1983605813","https://openalex.org/W1985572218","https://openalex.org/W1986673931","https://openalex.org/W1998237043","https://openalex.org/W1999117743","https://openalex.org/W2007253531","https://openalex.org/W2009548611","https://openalex.org/W2024529821","https://openalex.org/W2032832927","https://openalex.org/W2033132953","https://openalex.org/W2047748360","https://openalex.org/W2057393088","https://openalex.org/W2059158127","https://openalex.org/W2064837716","https://openalex.org/W2073345658","https://openalex.org/W2073534246","https://openalex.org/W2075994083","https://openalex.org/W2081537037","https://openalex.org/W2084481462","https://openalex.org/W2085255982","https://openalex.org/W2089319338","https://openalex.org/W2089501505","https://openalex.org/W2102774199","https://openalex.org/W2112545334","https://openalex.org/W2116281255","https://openalex.org/W2126435985","https://openalex.org/W2130034840","https://openalex.org/W2133256471","https://openalex.org/W2145270758","https://openalex.org/W2153787367","https://openalex.org/W2155340986","https://openalex.org/W2157677292","https://openalex.org/W2161674848","https://openalex.org/W2171440185","https://openalex.org/W2323256318","https://openalex.org/W2399846500","https://openalex.org/W2520432709","https://openalex.org/W4205718468","https://openalex.org/W4213243604","https://openalex.org/W4241819752"],"related_works":["https://openalex.org/W2024529821","https://openalex.org/W1452621040","https://openalex.org/W2036319089","https://openalex.org/W2526169528","https://openalex.org/W3091892967","https://openalex.org/W2039130824","https://openalex.org/W2575443008","https://openalex.org/W2071339718"],"abstract_inverted_index":{"BACKGROUND:":[0],"Bromocriptine-QR":[1],"(a":[2],"quick-release":[3],"formulation":[4],"of":[5,81,95,125,134,144,167,229,263,271,279,311,315,322,332,345,410,467,491],"bromocriptine":[6],"mesylate),":[7],"a":[8,14,32,43,79,191,253,286,292,381,441],"dopamine":[9],"D2":[10],"receptor":[11],"agonist,":[12],"is":[13,493],"US":[15],"Food":[16],"and":[17,55,57,116,129,148,204,206,317,319,324,330,339,432,462,483],"Drug":[18],"Administrration-approved":[19],"treatment":[20,193],"for":[21,60,190,227,246],"type":[22,476],"2":[23,231,477],"diabetes":[24,478],"mellitus":[25],"(T2DM).":[26],"A":[27],"3070-subject":[28],"randomized":[29,180],"trial":[30],"demonstrated":[31],"significant,":[33,382,442],"40%":[34],"reduction":[35,384,444,470],"in":[36,42,100,110,217,275,302,353,385,388,445,448,471],"relative":[37,239,386,446,468],"risk":[38,240,387,447,469],"among":[39,368,376,428,436,475],"bromocriptine-QR-treated":[40,370,430],"subjects":[41,163,300,333,371,431,479],"prespecified":[44],"composite":[45,114,233,359],"cardiovascular":[46,76,98,153,248,360,414,472],"(CV)":[47],"end":[48,70,142,234,361,390,421,450],"point":[49,391,451],"that":[50,398,485],"included":[51,222],"ischemic-related":[52],"(myocardial":[53],"infarction":[54,209],"stroke)":[56],"nonischemic-related":[58],"(hospitalization":[59],"unstable":[61],"angina,":[62],"congestive":[63],"heart":[64,197],"failure":[65,198],"[CHF],":[66],"or":[67,188,210,412],"revascularization":[68,211],"surgery)":[69],"points,":[71],"but":[72],"did":[73],"not":[74,400],"include":[75],"death":[77,109,150],"as":[78,252],"component":[80],"this":[82,101,119,135,354,389,449,489],"composite.":[83],"The":[84,238,268],"present":[85],"investigation":[86,487],"was":[87,250,289,351,399],"undertaken":[88],"to":[89,182,185,215,224],"more":[90],"critically":[91],"evaluate":[92],"the":[93,111,123,132,139,218,230,244,247,261,276,296,346,357,419,464],"impact":[94,490],"bromocriptine-QR":[96,183,242,393,453,482,492],"on":[97,122,137,164,260,295],"outcomes":[99,221,249],"study":[102],"subject":[103],"population":[104],"by":[105,291,402],"(1)":[106],"including":[107],"CV":[108,141,149,232,280],"above-described":[112],"original":[113,465],"analysis":[115,121],"then":[117],"stratifying":[118],"new":[120],"basis":[124,262],"multiple":[126],"demographic":[127],"subgroups":[128],"(2)":[130],"analyzing":[131],"influence":[133],"intervention":[136],"only":[138],"\"hard\"":[140],"points":[143,235],"myocardial":[145,208],"infarction,":[146],"stroke,":[147],"(major":[151],"adverse":[152,473],"events":[154,281,366,374,426,434,474],"[MACEs]).":[155],"METHODS":[156],"AND":[157],"RESULTS:":[158],"Three":[159],"thousand":[160],"seventy":[161],"T2DM":[162],"stable":[165],"doses":[166],"\u22642":[168],"antidiabetes":[169],"medications":[170],"(including":[171],"insulin)":[172],"with":[173,196,243,256,306,327,336,392,452,481],"HbA1c":[174,310],"\u226410.0":[175],"(average":[176],"baseline":[177,309],"HbA1c=7.0)":[178],"were":[179,213,301,364,424],"2:1":[181],"(1.6":[184],"4.8":[186],"mg/day)":[187],"placebo":[189,378],"52-week":[192],"period.":[194],"Subjects":[195],"(New":[199],"York":[200],"Heart":[201],"Classes":[202],"I":[203],"II)":[205],"precedent":[207],"surgery":[212],"allowed":[214],"participate":[216],"trial.":[219],"Study":[220,299],"time":[223,283],"first":[225],"event":[226],"each":[228],"described":[236],"above.":[237],"comparing":[241],"control":[245],"estimated":[251],"hazard":[254],"ratio":[255],"95%":[257],"confidence":[258],"interval":[259],"Cox":[264],"proportional":[265],"hazards":[266],"regression.":[267],"statistical":[269],"significance":[270],"any":[272],"between-group":[273],"difference":[274],"cumulative":[277],"percentage":[278],"over":[282],"(derived":[284],"from":[285],"Kaplan-Meier":[287],"curve)":[288],"determined":[290],"log-rank":[293,396,456],"test":[294],"intention-to-treat":[297],"population.":[298],"reasonable":[303],"metabolic":[304],"control,":[305],"an":[307],"average":[308],"7.0\u00b11.1,":[312],"blood":[313],"pressure":[314],"128/76\u00b114/9,":[316],"total":[318],"LDL":[320],"cholesterol":[321],"179\u00b142":[323],"98\u00b132,":[325],"respectively,":[326],"88%,":[328],"77%,":[329],"69%":[331],"being":[334],"treated":[335,480],"antidiabetic,":[337],"antihypertensive,":[338],"antihyperlipidemic":[340],"agents,":[341],"respectively.":[342],"Ninety-one":[343],"percent":[344],"expected":[347],"person-year":[348],"outcome":[349],"ascertainment":[350],"obtained":[352],"study.":[355],"Respecting":[356],"CV-inclusive":[358],"point,":[362,422],"there":[363,423],"39":[365],"(1.9%)":[367],"2054":[369,429],"versus":[372],"33":[373],"(3.2%)":[375],"1016":[377,437],"subjects,":[379,439],"yielding":[380,440],"39%":[383],"exposure":[394,454],"(P=0.0346;":[395],"test)":[397],"influenced":[401],"age,":[403],"sex,":[404],"race,":[405],"body":[406],"mass":[407],"index,":[408],"duration":[409],"diabetes,":[411],"preexisting":[413],"disease.":[415],"In":[416],"addition,":[417],"regarding":[418],"MACE":[420],"14":[425],"(0.7%)":[427],"15":[433],"(1.5%)":[435],"placebo-treated":[438],"52%":[443],"(P<0.05;":[455],"test).":[457],"CONCLUSIONS:":[458],"These":[459],"findings":[460],"reaffirm":[461],"extend":[463],"observation":[466],"suggest":[484],"further":[486],"into":[488],"warranted.":[494],"CLINICAL":[495],"TRIAL":[496],"REGISTRATION:":[497],"URL:":[498],"http://clinicaltrials.gov.":[499],"Unique":[500],"Identifier:":[501],"NCT00377676.":[502]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2118123147","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
